Skip to content

Analysis of Risk Factors for Secondary Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury and Construction of a Prognostic Prediction Model

Analysis of Risk Factors for Secondary Paroxysmal Sympathetic Hyperactivity in Patients with Traumatic Brain Injury and Construction of a Prognostic Prediction Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120889
Enrollment
Unknown
Registered
2026-03-22
Start date
2026-03-22
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic brain injury

Interventions

The PSH group and the non-PSH group:None

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed with TBI through CT or MRI examination, and the severity of brain injury was evaluated based on the Glasgow Coma Scale (GCS) score (a score of 13-15 indicates mild brain injury, 9-12 indicates moderate brain injury, and 3-8 indicates severe brain injury); 2. Survival time >= 28 days; 3. Age > 18 years old; 4. The medical records are complete;

Exclusion criteria

Exclusion criteria: 1. Diagnose aneurysms, vascular malformations, Moyamoya disease, stroke, brain tumors and spontaneous cerebral hemorrhage; Pregnancy or lactation 2. Severe abnormalities in liver and kidney functions 3. Abnormal immune function 4. Severe neurological dysfunction left over from a past medical history 5. Schizophrenia and other mental and psychological disorders

Design outcomes

Primary

MeasureTime frame
Glasgow Prognostic Score;

Secondary

MeasureTime frame
Overall survival period of the patient;

Countries

China

Contacts

Public ContactLing You

Yuebei People’s Hospital

1060200956@qq.com+86 751 6913409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026